← All trials
NCT04800224
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 12, 2021
- Primary completion
- Jun 30, 2021
- Completion date
- Jul 30, 2021
- First posted
- Mar 16, 2021
- Last posted
- Apr 14, 2021
- Enrollment
- 200
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- D'Or Institute for Research and EducationLead sponsor
- D'Or Institute for Research and EducationReponsible party - principal investigator
- Apis Flora Industrial e Comercial LtdaCollaborator
- Hospital São LuizOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.